The Joe Tippens Protocol was created by a cancer patient who was given only three months to live after being diagnosed with stage four brain cancer. He was taking the standard cancer treatment medications and found that these were not effective. He then began researching and came across the information on fenbendazole, which is used to treat parasites and has been shown to be effective in mice. He began using the medication and combined it with curcumin and CBD and his cancer has since been completely eliminated.
The benzimidazole anthelmintic fenbendazole (methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl) carbamate) exerts broad antiparasitic activities by binding to and disrupting the equilibrium of tubulin microtubules in helminthes by targeting b-tubulin subunits, inhibiting their polymerization, and destabilizing the cytoskeleton. Recent studies have demonstrated that fenbendazole may exhibit antitumor activity, via the same mechanism of action  and by interacting with tumor cell nuclei directly.
We examined the effect of fenbendazole on the radiation sensitivity of EMT6 colon carcinoma cells in vitro. Cells were treated with graded doses of docetaxel in the presence or absence of fenbendazole for 2 h, and the surviving fractions were determined by clonogenic assay. The results are shown as the geometric means+/- SEM of surviving fractions for unirradiated cultures, and as the yield-corrected surviving fractions for cultures irradiated at various time points after the completion of treatment. Severe hypoxia significantly increased the toxicity of 2-h treatments with fenbendazole, but not 24-h treatments.
The woman was initially being treated with pembrolizumab monotherapy, which has been reported to have no clinically significant hepatotoxicity. The patient reported that she had obtained the information on fenbendazole, a canine anthelmintic, from social media sites indicating that it was a cancer cure. fenbendazole stage 4 cancer